SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade.
Zhao M, Guo W, Wu Y, Yang C, Zhong L, Deng G, Zhu Y, Liu W, Gu Y, Lu Y, Kong L, Meng X, Xu Q, Sun Y.
Zhao M, et al. Among authors: gu y.
Acta Pharm Sin B. 2019 Mar;9(2):304-315. doi: 10.1016/j.apsb.2018.08.009. Epub 2018 Sep 5.
Acta Pharm Sin B. 2019.
PMID: 30972278
Free PMC article.